CIP-MCI

Cortical Information Processing in Mild Cognitive Impairment

Home_ICS

Home

Project

Partner

Info

 

Mr. Narayan Devkota
Chairman
Research Center for Applied Statistics - RECAS
P.O.BOX 15145

Kathmandu
15145 Nepal
T.: 977 1 4351242
Fax: 977 1 4423542
info@researchnepal.org

 

 Research Center for Applied Statistics ( RECAS) is a research center for the Health and medical research in different diseases that exist in Nepal.  RECAS in co-operation with Institute of Medicine,Tribhubhan University ( Department of Anatomy, Department of Radiology, Department of Neurology and Department of Pharmacology ), Institute of Ayurvedic Medicine and Institute of natural medicine seek  to investigate in Neurodegenerative  disorder, cognitive disorders and dementia in our area for both clinical activities to diagnosis of Alzheimer diseases and  herbal and Traditional Chinese medicine treatment  including Accupuncture  that exists in Nepal in both preventative and curative mode. The team focus on the ethnopharmacological approach to identify potential new drugs of Cognitive Disorder including Alzhimer diseases. The principal field of Investigation is the evaluation of Alzheimer diseases in environment especially in higher altitude by using pharmacological treatment after prevalence’s of AD, clinical  diagonosis of patients with different types of Dementia, especially using Herbal Medicine, Traditional Chinese medicine  and complementary medicine with Naturopathy. The team is cossist of the following Member. Prof Dr R.P. Uprite, - Physician,  Prof. Dr Taraman Amayta – specialist of Alzhimer Diseases, Dr Dhurba Adhikari – neurosurgeon and expert of Alzheimer’s diseases. Dr, Thakur Duwadi – Specialist of herbal medicine for alzhimer treatment , Prof dr. Surya  Bahadur karki- Naturopath, Dr – S. Pandey – Music therapist, Narayan devkota – statistician for data analysis and co-ordination of such team are Involved. 

 

The diagnosis of Mild Cognitive Impairment ( MCI) and Alzhimer disease is very difficult through symptoms only but can identify through  radiology test as well. After diagnosis of such patients having Alzheimer diseases with cognitive disordered, neurodegenerative diseases. These patients are in case control study under existing allopathic Chinese medicine as  common for them and additional dose of herbal medicine, traditional Chinese medicine with acupuncture  with Music therapy are used for their treatment. These Natural remedies such as Ayurvedic, Naturopathy ( Meditation ) and different of herbs as food and drugs supliment will given for the patient in  low cost have no side effect for the patients. After having the treatment of such patients we will refer for the follow up  them by using herbal and  traditional Chinese medicine, meditation and Acupunture for completely recovery of Memory, Enhancing cognitive , anti againg and  many other neurodegenerative diseases like hypertention,inflammation, oxidative stress, .

 

 There is ethnopharmacology approach  has provided lead to identify potential new herbal drugs for cognitive Disorder. Plants and their constitutes with pharmacological activities that may relevant for the treatment of cognitive disorder including enhansment of cholinergic function of central nervious system, anti-Inflammatory, antioxident activities . Many herbal plants have many drugs which are essential for the Alzhimer’s diseases and Mild cognitive Impairment. Eg. Anti- Che ( anticholinesterase. Alkaloids Isolated from the plants have been used for cognitive enhancing, Galantamine – Isolated from Lycoris radiate herbs which is also used for cognitive enhancing or antiagening, and Galanthus nivalis anve anti- dementis effect on using. Our plan is is to use orka, charungli, Bitter melon , angular loofah and neem plant are used as herbal drugs in our investigation.

 

The team of Haematologists participant from RECAS unit  identify the case of the patients of Alzheimer Diseases with Mild Cognitive Impairment ( MCI ) on the basis of  symptoms by using technology ( MRI, CT scan and EEG ) from the 4500 patients as a sample. From the 4500 patients sample patients in the age above 45 will consider in our sample on the basis of life expectancy of Nepalese,135 patients are taken as case control study under treatment under Chinese Medicine with Meditation. These patient are split into three category as Block in which Chinese medicine, Meditation with Music therapy in A. In block B Chinese medicine, Meditation  with Herbal ( Ayurvedic)  medicine are taken into account and in Block C, Chinese medicine, Meditation with acupuncture and acupressure are taken as a account in our study. These are carry out in 700m height for the A Block  , 1500m height for block B patients and 2500 m height for Block C category patient in Terai, Hills and Mountain area. In each six month the effectiveness of such things are taken into account. The food supplements stuff are consider for all case as a homeopathy part of treatment.

The Longitudinal case control  study will be consider for  evaluation for  Alzheimer disease on using the above treatment. Follow up treatment will be given for the patient on the basic of our finding on  Chinese medicine, Herbal medicine, Acupuncture and Acupressure, Meditation with music therapy .

 

We propose to search the best way of treatment of AD to predict who are the persons with MCI who progress to dementia through the identification of specific causative sequence  Improve variations and the analysis of cause of  environmental factor  and side effect less alternative medicine  with Chinese medicine in AD through Ethnopharmacology activities.

 

Research center for applied Statistics ( RECAS) is a Social  Research organization for Health, Education, Agriculture research. It conducts survey research and suggest to implement the survey finding or tries to implement such finding for the benefit of rural, downtrodden people. The health research team is well qualified for doing the in medical research. The principal field of Investigation is to evaluation of Alzhimer diseases through chinese medicine including Herbal, meditation, Music therapy in different altitudes.

 

Workpackage description

 

Workpackage number

PA

Start date or starting event:

32

 

Workpackage title: Pharmacological Activities

 

Participant id

 

 

 

RECAS

 

 

 

 

 

Person-months per part.

 

 

 

32

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Objectives

O5.1: To find  concrete symptoms cause of  in cases with close case controls study , with detailed diagnostic, neuropsychological and psychopathological data.

O5.2: To identify  best ways  of treatment of MCI and AD in case control study of the treatment of the patients among Chinese medicine, Herbal medicine, Acupuncture and Acupressure, Meditation and Music therapy.

O5.3: To analyse component  and consistitute  in plants which are usefull for AD for future manufacture of medicine for AD and MCI.

O5.4: To study possible correlations between treatment procedure with  environment  factors according to altitude.

 

Description of work

T5.1: Creation of  diagnosis  procedure for AD and MCI for the patients:

- Management of patients samples collection from three teaching hospital of Nepal  in different location ( IOM, KMCTH, and INM and BMC ) centres.

-  Treatment of the AD and MCI  with best Chinese medicine, Meditation and other unit ( Herbal, Music therapy, Acupuncture and Acupressure ) for the sample patients including food supplements in three category.

- Preparation for database collection of detailed diagnostic, neuropsychological and psychopathological data on patient and their improvement in case- control study.

T5.2:  Classify the patients into three category into Block A, Block B and Block C for treatment  with Chinese medicine, Meditation and other unit ( Herbal, Music therapy, Acupuncture and Acupressure ) for the sample patients including food supplements on them and case-control association of  studies on patients:

- Initial Chinese medicine will be used for the first to control the disease and use other supplementary treatments that exist in Nepal as legal one in connection to them.

-  The weekly date is taken from the patient by questionnaire from the patient and day to day longitudinal date are taken from medical point of view from the them and analyze and adopt the doze according to doctors.

 - Statistical analysis stratified according to centre and correlation among them is taken under the supervision to the patients and follow up is made to them by using the complementary medicine one..

T5.3: To analyse the bio chemical analysis of the constituents for the AD for future manafucture of Drugs:

T5.4: To study possible correlations between  treatment methods with  environmental condition:

 

 

Deliverables

D5.1:  Daignosis of the patients from Teaching hospital  and date collection.

Full list of volunteers for all genetic studies

D5.2:  Treatment start for Identified patients and  analysis the date  for rate of  effectiveness of  treatment procedure. Final date analyze. 

D5.3: analyse the bio chemical components of the herbs and food supliment for the patients  Final data analysed

D5.4: treatment delivery –environment  analysis on best approach

Prepare publications

 

Milestones and expected result

M5.1: Study participants:  For diagnosis  of Ad and MCI patients 3 months

M5.2: collection complete with final  treatment  and other data collected; 28 months

M5.3: Statistical analysis complete with final data analysed for best treatment : 32 months

 

Home_ICS

Home

Project

Partner

Info